Test Cover Image of:  Heterocyclic Communications
Impact Factor

Heterocyclic Communications

Editor In Chief: Maged Henary

It is with a great deal of sadness to inform you of the death of one of our associate editors Professor Hidetoshi Yamada. We deeply thank for his support, work, and contribution to the journal.

Since 1st January 2019 Heterocyclic Communications has changed the publishing model to Open Access.

Articles accepted for publication in Heterocyclic Communications are subject to an Article Processing Charge of €1500

Your benefits:

  • Significant developments in heterocyclic chemistry
  • Synthetic routes to heterocyclic compounds with high biological activity
  • Imperative topics including theoretical analysis
  • Cutting-edge trends
  • Easy traceability through detailed experimental descriptions
  • Long-time preservation of the content (archiving) with Portico

Heterocyclic Communications (HC) is an open-access, peer-reviewed journal publishing preliminary communications, research articles, and reviews on significant developments in all phases of heterocyclic chemistry, including general synthesis, natural products, computational analysis, considerable biological activity and inorganic ring systems. Clear presentation of experimental and computational data is strongly emphasized. Heterocyclic chemistry is a rapidly growing field. By some estimates original research papers in heterocyclic chemistry have increased to more than 60% of the current organic chemistry literature published. This explosive growth is even greater when considering heterocyclic research published in materials science, physical, biophysical, analytical, bioorganic, pharmaceutical, medicinal and natural products journals. There is a need, therefore, for a journal dedicated explicitly to heterocyclic chemistry and the properties of heterocyclic compounds.

  • Development of novel synthetic methods
  • Significant improvement of known synthetic methods
  • Chemistry of natural products
  • Superior biological activity of novel heterocyclic compounds, rational design and synthesis of new drug candidates targeting specific biological receptors
  • Application of heterocyclic compounds as probes for biomolecules in biophysical and bioanalytical chemistry
  • Development of new substrates and catalysts in materials chemistry

Article formats
Preliminary Communications, Original Research Articles, Review Articles

> Information on submission process

Journal Metrics

5-year Impact Factor
Cite Score
Impact Factor
SCImago Journal Rank
Source Normalized Impact per Paper


Heterocyclic Communication was previously published by Freund Publishing House Ltd.

Other publications in the field

Abstracting & Indexing

Heterocyclic Communications is covered by the following services:

  • Baidu Scholar
  • Cabells Journalytics
  • Chemical Abstracts Service (CAS) - CAplus
  • Chemical Abstracts Service (CAS) - SciFinder
  • Chronos Hub
  • CNKI Scholar (China National Knowledge Infrastructure)
  • CNPIEC - cnpLINKer
  • Dimensions
  • DOAJ (Directory of Open Access Journals)
  • EBSCO (relevant databases)
  • EBSCO Discovery Service
  • Genamics JournalSeek
  • Google Scholar
  • Japan Science and Technology Agency (JST)
  • J-Gate
  • Journal Citation Reports/Science Edition
  • JournalGuide
  • JournalTOCs
  • KESLI-NDSL (Korean National Discovery for Science Leaders)
  • Microsoft Academic
  • MyScienceWork
  • Naver Academic
  • Naviga (Softweco)
  • Primo Central (ExLibris)
  • ProQuest (relevant databases)
  • Publons
  • QOAM (Quality Open Access Market)
  • ReadCube
  • Reaxys
  • SCImago (SJR)
  • Semantic Scholar
  • Sherpa/RoMEO
  • Summon (ProQuest)
  • TDNet
  • Ulrich's Periodicals Directory/ulrichsweb
  • WanFang Data
  • Web of Science - Current Contents/Physical, Chemical and Earth Sciences
  • Web of Science - Science Citation Index Expanded
  • WorldCat (OCLC)
  • Yewno Discover

Volume 26 (2020): Issue 1 (Jan 2020)

Manuscripts should be submitted to the journal via online submission system Editorial Manager available for this journal at https://www.editorialmanager.com/hcc In case of problems, please contact the Editorial Office of this journal at anna.binczewska@degruyter.com.


For detailed information, please see Instruction for Authors.


Unpublished material: Submission of a manuscript implies that the work described is not copyrighted, published or submitted elsewhere, except in abstract form. The corresponding author should ensure that all authors approve the manuscript before its submission.

Ethical conduct of research: The authors must describe and confirm safeguards to meet ethical standards when applicable. See Editorial Policy for details.

Conflict of interest: When authors submit a manuscript, they are responsible for recognizing and disclosing financial and/or other conflicts of interest that might bias their work and/or could inappropriately influence his/her judgment. If no specified acknowledgement is given, the Editors assume that no conflict of interest exists.

Copyright: All authors retain copyright, unless – due to their local circumstances – their work is not copyrighted. The copyrights are governed by the Creative-Commons Attribution Only license (CC-BY) which is compliant with Plan-S. We may also publish a paper under CC-BY-NC-ND license on author's request. The corresponding author grants the journal the license to use of the article, by signing the License to Publish. Scanned copy of license should be sent to the journal, as soon as possible.

Authorship: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be named in an Acknowledgement section. The corresponding author should ensure that all appropriate co-authors (according to the above definition) and no inappropriate co-authors are included in the author list of the manuscript, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Peer Review process: The Editors reserve the right to decline the submitted manuscript without review, if the studies reported are not sufficiently novel or important to merit publication in the journal. Manuscripts deemed unsuitable (insufficient originality or of limited interest to the target audience) are returned to the author(s) without review. The Editor seeks advice from experts in the appropriate field. Research articles and communications are refereed by a minimum of two reviewers, review papers by at least three. Authors are requested to suggest persons competent to review their manuscript. However, please note that this will be treated only as a suggestion, and the final selection of reviewers is exclusively the Editor's decision. The final decision of acceptance in made by Managing Editor or, in case of conflict, by the Editor-in-Chief.

Scientific Misconduct: This journal publishes only original manuscripts that are not also published or going to be published elsewhere. Multiple submissions/publications, or redundant publications (re-packaging in different words of data already published by the same authors) will be rejected. If they are detected only after publication, the journal reserves the right to publish a Retraction Note. In each particular case, Editors will follow COPE’s Core Practices and implement the advice.


Effective 1st January 2016, authors from an institution affiliated with either the Association of Dutch Universities (VSNU), the Consortium of Swiss Academic Libraries or some UK libraries participating in the Jisc Collections SMP may publish primary research and review articles open access in any of De Gruyter's Online Open journals at a discount of 90% of the APC price. For more information and to confirm whether your institution is eligible please see the following:

The Netherlands: https://www.degruyter.com/page/1461
The UK: https://www.degruyter.com/page/1462
Switzerland: https://www.degruyter.com/page/1463

Editor-in Chief
Maged Henary, Department of Chemistry, Georgia State University, Atlanta, USA (mhenary1@gsu.edu)

Managing Editor
Anna Binczewska, anna.binczewska@degruyter.com

Honorary Editor
Lucjan Strekowski, Georgia State University, Atlanta, USA (lucjan@gsu.edu)

Associate Editors
Alfons Baumstark, Georgia State University, Atlanta, USA (abaumstark@gsu.edu)
Naresh Gunaganti, Northeastern University, Boston, USA (naresh.gunaganti@gmail.com)
Ajay Mallia, Georgia Gwinnett College, Lawrenceville, USA (amallia@ggc.edu)
Kun Zhao, Chubu University, Kasugai, Japan (kunzhao13@gmail.com)
Wei Zhu, Northwestern University, Evanston, USA (wei.zhu@northwestern.edu)

Assistant Editor
Headar Abuirqeba, Catholic University of America, Washington DC, USA

Editorial Board
S. Abu-Orabi, Association of Arab Universities, Amman, Jordan (abuorabi@excite.com)
S. Achilefu, Washington University, St. Louis, USA (achilefus@mir.wustl.edu)
E.B. Arevalo-Garcia, Educational Research Institute, Warsaw, Poland (ebarevalog@gmail.com)
M. Brimble, University of Auckland, Auckland, New Zealand (m.brimble@auckland.ac.nz)
R.A. Bunce, Oklahoma State University, Stillwater, USA (rab@okstate.edu)
D. Das, Johns Hopkins School of Medicine, Baltimore, USA (ddas7@jhmi.edu)
M. Elliott, University of Cardiff, Cardiff, UK (elliottmc@cardiff.ac.uk)
D.C. Gautam, University of Rajasthan, Jaipur, India (drdcgautam@yahoo.co.in)
M.W. Germann, Georgia State University, Atlanta, USA (mwg@gsu.edu)
S. Gozem, Georgia State University, Atlanta, USA (sgozem@gsu.edu)
D. Hamelberg, Georgia State University, Atlanta, USA (dhamelberg@gsu.edu)
H. Kiyota, Okayama University, Okayama, Japan (kiyota@okayama-u.ac.jp)
K. Kiec-Kononowicz, Jagiellonian University, Kraków, Poland (mfkonono@cyf-kr.edu.pl)
M. Kumar, University of Rajasthan, Jaipur, India (mahendrakpathak@gmail.com)
H. Nishino, Kumamoto University, Kumamoto, Japan (nishino@sci.kumamoto-u.ac.jp)
T. Okano, Jikei University, Tokyo, Japan (okano@jikei.ac.jp)
S.S. Panda, Augusta University, Augusta, USA (sipanda@augusta.edu)
S.E. Patterson, UMN Center for Drug Design, Minneapolis, USA (patte219@umn.edu)
J. Reddy, Dr. Jagath Reddy's Heterocyclics, Hyderabad, India (jagathreddy@heterocyclics.com)
S. Routier, University of Orléans, Orléans, France (sylvain.routier@univ-orleans.fr)
A. Rykowski, University of Podlasie, Siedlce, Poland (rykowski@ap.siedlce.pl)
F. Saczewski, Medical University of Gdansk, Gdansk, Poland (saczew@amg.gda.pl)
S.W. Schneller, University of Auburn, Auburn, USA (schnest@auburn.edu)
B.C.G. Söderberg, University of West Virginia, Morgantown, USA (bjorn.soderberg@mail.wvu.edu)
V. Traven, Russian University of Chemical Technology, Moscow, Russia (traven@muctr.edu.ru)
B. Wang, Georgia State University, Atlanta, USA (wang@gsu.edu)
K. Weisz, Ernst Moritz Arndt University, Greifswald, Germany (weisz@uni-greifswald.de)
P.-F. Xu, Lanzhou University, Lanzhou, China (xupf@lzu.edu.cn)
P. Zajdel, Jagiellonian University Medical College, Kraków, Poland (pawel.zajdel@uj.edu.pl)
N. Zaware, Mount Sinai School of Medicine, New York, USA (nzaware@gmail.com)
A. Zawisza, University of Łódź, Łódź, Poland (aniazawisza@poczta.onet.pl)

Language Editors
Stephen Hill, The ōbex project, UK
Alison Jones, The ōbex project, UK
Joanna Kulaszewska, The ōbex project, UK
Rosie Madge, The ōbex project, UK
Martin Owton, The ōbex project, UK
Hugh Patrick, The ōbex project, UK
Nour Tanbouza, The ōbex project, UK
Amy Catherine Angie Verhagen, The ōbex project, UK
Rebecca Williams, The ōbex project, UK
Rachel Whiteside, The ōbex project, UK

Bogumiła Zuga 32A Str.
01-811 Warsaw, Poland
T: +48 22 701 50 15

Editorial Contact
Dr Anna Binczewska, Managing Editor
De Gruyter
E-mail: anna.binczewska@degruyter.com



Audience: researchers in the field of heterocyclic, bioorganic, bioinorganic and medicinal chemistry